These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma. Taylor DA; Jensen MW; Aikman SL; Harris JG; Barnes PJ; O'Connor BJ Am J Respir Crit Care Med; 1997 Dec; 156(6):1731-7. PubMed ID: 9412548 [TBL] [Abstract][Full Text] [Related]
3. Bronchial asthma and the role of beta 2-agonists. Cochrane GM Lung; 1990; 168 Suppl():66-70. PubMed ID: 1974684 [TBL] [Abstract][Full Text] [Related]
4. Long-term effects of formoterol and salbutamol on bronchial hyperreactivity and beta-adrenoceptor density on lymphocytes in children with bronchial asthma. Kozlik-Feldmann R; von Berg A; Berdel D; Reinhardt D Eur J Med Res; 1996 Jul; 1(10):465-70. PubMed ID: 9438143 [TBL] [Abstract][Full Text] [Related]
5. [A new beta-2 sympathomimetic drug with longer effectiveness. Comparison with current beta-2 sympathomimetic drugs in therapy of bronchial asthma in childhood]. von Berg A; Berdel D Monatsschr Kinderheilkd; 1993 Jan; 141(1):53-8. PubMed ID: 8095323 [TBL] [Abstract][Full Text] [Related]
6. Salmeterol: a novel, long-acting beta 2-agonist. Meyer JM; Wenzel CL; Kradjan WA Ann Pharmacother; 1993 Dec; 27(12):1478-87. PubMed ID: 7905757 [TBL] [Abstract][Full Text] [Related]
7. Differential effect of formoterol on adenosine monophosphate and histamine reactivity in asthma. Nightingale JA; Rogers DF; Barnes PJ Am J Respir Crit Care Med; 1999 Jun; 159(6):1786-90. PubMed ID: 10351919 [TBL] [Abstract][Full Text] [Related]
8. Loss of bronchoprotection with salmeterol. D'Urzo AD Chest; 1996 Jul; 110(1):306. PubMed ID: 8681659 [No Abstract] [Full Text] [Related]
10. [Exercise-induced asthma; clinical presentation, pathogenesis and treatment]. Gawlewicz-Mroczka A; Mastalerz L; Nizankowska-Mogilnicka E Pol Arch Med Wewn; 2004 Jun; 111(6):721-6. PubMed ID: 15508796 [No Abstract] [Full Text] [Related]
11. [Duration of the therapeutic effect of a beta 2 stimulant (procaterol hydrochloride) in patients with asthmatiform bronchopathies]. Cammarata A; Mazzarella G; Grella E; Liccardo G Arch Monaldi Mal Torace; 1988; 43(2):131-40. PubMed ID: 2908377 [No Abstract] [Full Text] [Related]
13. Bronchodilator therapy in the management of acute asthma. Moan MJ; Fanta CH Compr Ther; 1995 Aug; 21(8):421-7. PubMed ID: 8536441 [TBL] [Abstract][Full Text] [Related]
14. Beta-adrenergic bronchodilators. Nelson HS N Engl J Med; 1995 Aug; 333(8):499-506. PubMed ID: 7623883 [No Abstract] [Full Text] [Related]
15. Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature. Bisgaard H Pediatr Pulmonol; 2000 Mar; 29(3):221-34. PubMed ID: 10686044 [TBL] [Abstract][Full Text] [Related]
16. [Changing understanding and definition of bronchial asthma]. Makino S Nihon Rinsho; 1996 Nov; 54(11):2881-5. PubMed ID: 8950924 [TBL] [Abstract][Full Text] [Related]
17. Drugs for asthma. Treat Guidel Med Lett; 2008 Dec; 6(76):83-90. PubMed ID: 19029869 [No Abstract] [Full Text] [Related]
18. Exercise-induced asthma. Diagnostic clues with recommendation for treatment. Smith SB Postgrad Med; 1985 Jun; 77(8):42-5, 49-50. PubMed ID: 2860642 [TBL] [Abstract][Full Text] [Related]
19. The drug therapy of asthma: directions for the 21st century. Barnes PJ Agents Actions Suppl; 1988; 23():293-313. PubMed ID: 2902765 [TBL] [Abstract][Full Text] [Related]
20. Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma. Aldridge RE; Hancox RJ; Robin Taylor D; Cowan JO; Winn MC; Frampton CM; Town GI Am J Respir Crit Care Med; 2000 May; 161(5):1459-64. PubMed ID: 10806139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]